A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.

New findings confirm that partial-breast and reduced-dose radiotherapy effectively treat low-risk early-stage breast cancer ...

Benign and cancerous calcium phosphate deposits that may look identical on a mammogram have distinct differences in their ...

During a live event, Christine Bestvina, MD, reviewed outcomes from the phase 3 KRYSTAL-12 and CodeBreak 200 trials in the ...

New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in gastrointestinal cancer.

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.